“The supply chain has already been stressed over the past few years, but as we go through the fall and into the winter, we’re going to have some real challenges” due to Covid-19, Michael Osterholm, the center’s director, told STAT.
Forty-three percent, or 67 out of 156, of acute critical care drugs are in shortage, including antibiotics, blood thinners and sedatives, according to the center.
Experts predict a fivefold jump in demand for midazolam, a common sedative, and a tenfold increase in the use of cisatracurium, a muscle relaxant, STAT reported.
They also predict more COVID-19 hot spots to pop up.
“This time, we may approach a surge not with five or six hot spots, but maybe something like 30 or more hot spots,” Stephen Schondelmeyer, another co-principal investigator at the center, told STAT. “If they’re all having a surge at the same time, we don’t have the ability to shift supplies around as we tried to do in the spring.”
Read the full report here.
More articles on pharmacy:
Participant in AstraZeneca’s Brazil COVID-19 trial who died didn’t get vaccine
12 drugs being tested as COVID-19 treatments
Trump’s $200 Medicare drug card plan may violate election law, HHS lawyer says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
